(HealthDay News) -- Here are the latest clinical trials,
Anti-Nicotine Vaccine (Smoking Cessation)
This study will evaluate how an anti-nicotine vaccine. It's
designed to produce antibodies that absorb nicotine in your blood,
reducing nicotine levels in your brain and helping you to quit
The research site is in Winston-Salem, N.C.
This study will evaluate an investigational drug as an add-on
treatment to an approved antidepressant. Candidates must be aged 18
to 65 and diagnosed with major depressive disorder.
The research site is in Atlanta, Ga.
This study seeks people with cancer-related pain. If you
qualify, you may receive study-related medical evaluations at no
cost, and compensation for time and travel.
The research site is in Laguna Hills, Calif.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.